baber/WOPTO huggingface dataset:
Patent NZ-511111-A (NZ)
Title: Dispensing lid with a spout and adjustable discharge valve and a manually operable air bleed valve to all controlled dispensing
Inventor: KILIAN MICHAEL
IPC: B65D51/16
Filed: 1999-09-13
Abstract: The dispensing lid 10 for the gravity feed dispensing of a liquid includes a main body 12 defining a cavity 14 and adapted, by a screw thread 16, for releasably attaching any lid 10 to the container in a sealing manner. Spout 18 extends from the main body 12 and is fitted with an adjustable discharge valve 20 for varying the rate at which liquid flows through the spout 18. Air bleed passage 22 is formed in the lid for enabling fluid communication between the cavity 14 and the external atmosphere. The lid 10 also includes a manually operable air bleed valve 24 for selectively opening and closing the air bleed passage 22. Air bleed valve 24 is biased to normally close the passage 22. When the lid 10 is attached to a container by the screw thread 16 liquid can be dispensed or poured through the spout 18 by action of gravity at a rate dependent on the position or state of both valves 20 and 24
Patent NZ-512730-A (NZ)
Title: A immunization procedure against chlamydia infection using an attenuated bacteria comprsing a plasmid with a major outer membrane protein (MOMP) from chlamydial
Inventor: MURDIN ANDREW D
IPC: C12N15/87
Filed: 1999-12-02
Abstract: An attenuated bacteria harbouring a plasmid vector comprising a nucleic acid molecule encoding a major outer membrane protein (MOMP) of a strain of Chlamydia or a fragment thereof which generates a MOMP specific immune response and a eukaryotic promoter operatively coupled to the nucleic acid molecule for expression of the MOMP or fragment thereof in a host but not in the attenuated bacteria is described. The bacteria can be used in the manufacture of a medicament for immunizing a host against infection caused by strain of Chlamydia.
Patent NZ-516838-A (NZ)
Title: Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
Inventor: UHLMANN EUGEN
IPC: C12N15/87
Filed: 2000-07-20
Abstract: Conjugates and methods for their production, and to the use of these conjugates for transporting low molecular weight compounds and macromolecules via biological membranes, in particular, for transporting molecules in cells are disclosed. Also disclosed are medicaments, diagnostic agents and test kits in which these conjugates are present or introduced.
Patent NZ-517828-A (NZ)
Title: Inhibitors having activity against mammalian factor Xa
Inventor: ZHU BING-YAN
IPC: A61K31/4178
Filed: 2000-09-15
Abstract: Compounds of formula A-Q-D-E-G-J-X in which D is a direct link, a substituted or unsubsituted phenyl or naphtyl gourp or a heterocyclic ring system; G is substituted or unsubstituted phenyl or a heterocyclic ring system; X is a substituted or unsubstituted phenyl or naphtyl group or a heterocyclic ring system; and the other variables are as defined in the claims, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed, These compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.
Patent NZ-519801-A (NZ)
Title: Denture adhesive compositions comprising a polymeric activator
Inventor: WONG EDDIE
IPC: A61K6/00
Filed: 2000-10-13
Abstract: A denture adhesive composition is disclosed and comprises a polymeric activator in an amount of up to about 3 percent by weight based on the total weight of the denture adhesive composition; wherein the activator is selected from the group consisting of: polymethacrylic acid, polyacrylic acid, polyitaconic acid, polycitraconic acid, and a monovalent alkali metal cation salt thereof, wherein the activator is present in an amount of 0.1% to 2% by weight based on the total weight of the denture adhesive composition. This composition exhibits enhanced adhesive performance and reduces oozing and incidence of food occlusion.
Patent NZ-525486-A (NZ)
Title: Combination of HMG-COA reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia
Inventor: BOVA DAVID J
IPC: A61K9/22
Filed: 1998-07-31
Abstract: The disclosure relates to solid pharmaceutical combinations for oral administration comprising nicotinic acid or a nicotinic acid compound or mixtures thereof in an extended release form and an HMG-CoA reductase inhibitor, which are useful for altering lipid levels in subjects suffering from, for example, hyperlipidemia and atherosclerosis, without causing drug-induced hepatotoxicity, myopathy or rhabdomyolysis. The disclosure also relates to methods of altering serum lipids in subjects to treat, for example, hyperlipidemia in hyperlipidemics, lipidemia in normolipidemics diagnosed with or predisposed to cardiovascular disease, and atherosclerosis, by administering such oral solid pharmaceutical combinations once per day as a single dose during the evening hours, without causing drug-induced hepatotoxicity, myopathy or rhabdomyolysis, or without causing in at least an appreciable number of individuals drug-induced hepatotoxicity, myopathy or rhabdomyolysis to such a level that discontinuation of such therapy would be required. More particularly, the disclosure concerns oral solid pharmaceutical combinations comprised of, for example, (1) an HMG-CoA reductase inhibitor for immediate or extended release, (2) nicotinic acid, a nicotinic acid compound or mixtures thereof, and (3) a swelling agent to form a sustained release composition for extended release of the nicotinic acid or nicotinic acid compound or mixtures thereof for nocturnal or evening dosing for reducing serum lipids and increasing HDL-cholesterol. In accordance with the disclosure, and by way of example, a composition for oral administration during the evening hours to alter serum lipids comprised of nicotinic acid and hydroxypropyl methylcellulose in the form of an extended or sustained release tablet or caplet coated with a coating comprising an HMG-CoA reductase inhibitor in immediate release form is disclosed. Also in accordance with the disclosure, the pharmaceutical combinations may include a nonsteroidal anti-inflammatory agent for reducing the capacity of nicotinic acid or nicotinic acid compounds to provoke flushing reactions in individuals. (62) Divided out of 502522
Patent NZ-533380-A (NZ)
Title: Systems and methods of bonding materials
Inventor: HILL DAVID A
IPC: B27G11/00
Filed: 2004-06-08
Abstract: Disclosed is a method of dispensing adhesive, comprising: Conveying a piece of material along a processing path under an adhesive dispenser, and Dispensing adhesive through an oscillating aperture on to the material, wherein the dispensing step includes separately mixing rapid gelling adhesive components at plural stations arranged across the processing path while oscillating an adhesive projection path at each station.
Patent NZ-535416-A (NZ)
Title: Control of packet network-based service servers using in particular DTMF signals
Inventor: LUEKEN JOACHIM
IPC: H04L29/08
Filed: 2002-08-30
Abstract: A method of controlling a network service with a packet switched network (9), a service server (12) arranged in the packet switched network with the aid of which the network service ins implemented; a communication path (2, 7, 26, 19 and 25) by way of the packet switched network for forwarding an information flow between a first subscriber (1) and a second subscriber (24) and control signals to control the network service, which are able to be tapped off from the information flow with the following steps: a) establishment of the communication path; b) activation of the tapping off during the course of establishment of the communication path; c) forwarding of the tapped of control signals by way of a signaling network (15) to the service server and d) control of the network service by the service server taking into account the forwarded control signals.
Patent NZ-536619-A (NZ)
Title: New etonogestrel esters and their use as contraceptives
Inventor: DE NIJS HENRIK
IPC: A61K31/57
Filed: 2003-05-22
Abstract: Disclosed are new progestogen esters, etonogestrel decanoate, etonogestrel undecanoate, and etonogestrl dodecanoate. Also disclosed is the use of these esters for male or female contraception and/or male or female HRT.
Patent NZ-537326-A (NZ)
Title: Proteins with repetitive bacterial-IG-like (big) domains present in leptospira species
Inventor: KO ALBERT I
IPC: C07H21/04
Filed: 2002-05-20
Abstract: Disclosed are to three isolated DNA molecules that encode for proteins, BigL1, BigL2 and BigL3, in the Leptospira spirochaetes bacterium which have repetitive Bacterial-Ig-like (Big) domains and their use in diagnostic, therapeutic and vaccine applications. The isolated molecules encoding for BigL1, BigL2 and BigL3 proteins are useful for the diagnosis and prevention of infection with Leptospira species that are capable of producing disease in humans and other mammals.
Patent NZ-540072-A (NZ)
Title: Roof sheet clip assembly allowing for sliding of sheet relative to roof structure
Inventor: BROWN KARL JAMES
Filed: 2005-05-13
Abstract: Clip member 2 is engageable with a roofing sheet (not shown) and has outwardly directed feet located slidably in a track formed by lugs 9. Bracket member 6 is attachable to the roofing structure (not shown).
Patent NZ-545163-A (NZ)
Inventor: WINTERTON GEORGE BARRY
Filed: 2006-02-08
Abstract: A marine beach mooring system includes a boat powered winch 1 and a further independent mechanism 4 which may also be a winch, respectively winding bow and stern anchor lines of at least 50 metres each. The winches can be remote controlled to operate independently or in tandem using wireless transmitter/receiver system 2, 3, 5. To get people on to the beach without getting their pants wet, the bow anchor is dropped and the boat is allowed to come back to the beach with the bow line coming off winch 1. At the beach the people disembark and set the beach anchor. The boat is then winched off the beach by the bow winch, the stern line being eased. To get off the beach, the boat is winched back to the beach using the stern winch, at the same time easing the bow line, the people get on the boat, the stern anchor is lifted and stowed and the boat is then winched off the beach using the bow winch and bow line.
Patent NZ-547492-A (NZ)
Title: Optimization of gene expression analysis using immobilized capture probes of different lengths and densities
Inventor: SEUL MICHAEL
IPC: C12Q1/68
Filed: 2004-10-26
Abstract: Disclosed is a method of obtaining similar signal intensities from hybridization of different sets of the oligonucleotide probes to a set of cognate targets, in a hybridization assay that comprises sets of probes of different lengths on different solid phase carriers and sets of targets of different lengths, wherein annealing of a set of probes with cognate targets generates a signal intensity, wherein a cumulative signal intensity from said annealing is determined, the method comprising: (i) selecting probe lengths and densities for said sets of probes, wherein probes include different subsequences such that at least one subsequence is complementary to a subsequence in a cognate target; wherein probes for longer cognate targets are longer in length than probes for shorter cognate targets and wherein the density for longer probes is lower than the density for shorter probes, (ii) producing said probes and affixing said probes to different solid phase carriers at a selected density, (iii) annealing said target to said probes, wherein signal intensities of probes and targets of different lengths are about the same.
Patent NZ-548361-A (NZ)
Title: Porous bodies and method of production thereof
Inventor: COOPER ANDREW IAN
IPC: C11D17/00
Filed: 2004-12-23
Abstract: Disclosed are porous bodies soluble in non-aqueous media comprising a three dimensional, oil and water emulsion-templated, open-cell lattice comprising: a) 10 to 95 % by weight of a polymeric material which is soluble in the non-aqueous media, b) 5 to 90% by weight of a surfactant which is soluble in the non-aqueous media, and c) a water-soluble material which is not soluble in the non-aqueous media incorporated into the lattice to be dispersed in the non-aqueous media when said polymer (a) and surfactant (b) dissolve, wherein the porous bodies have an intrusion volume as measured by mercury porosimetry of at least 3 ml/g and being in the form of powders, beads or moulded bodies.
Patent NZ-564550-A (NZ)
Title: Macrocyclic inhibitors of hepatitis C virus
Inventor: RABOISSON PIERR JEAN-MARIE
IPC: C07D245/04
Filed: 2006-07-28
Abstract: The disclosure relates to macrocylic compounds of formula (I) having inhibitory activity on the replication of the hepatitis C virus (HCV), wherein the variables shown in formula (I) are as defined in the specification. It further discloses compositions comprising these compounds as active ingredients as well as processes for preparing these compounds and compositions. Bioavailable combinations of the inhibitors of HCV of formula (I) with ritonavir are also provided.
Patent NZ-569342-A (NZ)
Title: Compositions comprising whey proteins and lipids and processes of their preparation
Inventor: BAKKENE GUNNAR
IPC: A23K10/28
Filed: 2006-11-30
Abstract: NZ 569342 Disclosed is a composition comprising: a protein component consisting of whey protein concentrate in liquid and/or powdered form and/or concentrate of whey and/or non-concentrated whey and/or a mixture thereof, and other proteins selected from the group consisting of animal, plant, vegetable, marine, and microproteins, or hydrolysates thereof; wherein the source of the protein component comprises non-denatured whey protein in a concentration of no less than 40 % of the total concentration of protein, and wherein the concentration of any of the said other proteins is below 40% of the total concentration of protein, and wherein the denaturation percentage of the individual whey proteins in the composition is from 50 % to 99 % given a denaturation time of any of 1-10 minutes; and a lipid component not originating from the said protein component, wherein the lipid component is an edible fat or oil of marine origin comprising saturated, partially saturated, unsaturated fatty acids and wherein the lipid component comprises a high content of polyunsaturated fatty acids or functional derivatives thereof; wherein the protein and lipid components are simultaneously microparticulated.
Patent NZ-569718-A (NZ)
Title: Novel anti-IGF-IR antibodies and uses thereof
Inventor: GOETSCH LILIANE
IPC: A61K39/395
Filed: 2005-07-27
Abstract: Disclosed is an isolated antibody, or one of its functional fragments, said antibody or one of its said fragments being capable of binding to the human insulin-like growth factor I receptor IGF-IR and inhibiting the natural attachment of its ligands IGF1 and/or IGF2 and/or capable of specifically inhibiting the tyrosine kinase activity of said IGF-IR, comprising: - a light chain comprising at least three complementarity determining regions CDR of specific sequences, or three CDRs whose sequences have at least 80% identity after optimum alignment with the specific disclosed sequences; and - a heavy chain comprising at least three CDRs of specific sequences, or three CDRs whose sequence have at least 80% identity after optimum alignment with the specific disclosed sequences. (62) Divided Out of 552821
Patent NZ-573709-A (NZ)
Title: 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as hiv integrase inhibitor
Inventor: SHINKAI HISASHI
IPC: A61K31/4709
Filed: 2007-06-22
Abstract: Disclosed are 6-(heterocycle-substituted benzyl)-4-oxoquinoline compounds of formula [I] or a pharmaceutically acceptable salt, or solvate thereof, wherein the substituents are as defined in the specification. Also disclosed is the use of the compounds for the prophylaxis or treatment of a HIV infectious disease.
Patent NZ-579036-A (NZ)
Title: Video scrambling through relocation of pixel blocks
Inventor: JACOB STEPHANE JEAN-LOUIS
IPC: H04L9/14
Filed: 2008-02-14
Abstract: A method and a device for encoding visual information are disclosed. The device comprises image processing means configured to extract and process information from original source data for the visual information frame by frame; a pattern reader to store and convert each extracted frame into a predetermined number of patterns; and an encryption means coupled to the image processing means to rearrange the patterns into new positions and in a predetermined shape which is different to that of the original shape of the visual information, and generate a symmetrical encryption key for use in reorganizing the patterns to recreate the original source data for the visual information. A method and a device for decoding encoded visual information are disclosed. The device comprises means for receiving encoded data including encoded visual information divided into a predetermined number of patterns; a patterns reader to analyze and format pattern information of said data into preset pattern format; - a macro blocks DEMUX to reorganize the said pattern information using an encryption key into a pattern organization of original source data; and - a reverse encryption module to provide an encryption key for reorganizing said pattern information. The macro blocks DEMUX is configured to reorganize the patterns forming the encoded visual information from a predetermined shape which is different to that of the shape of the original visual information to the shape of the original visual information.
Patent NZ-579621-A (NZ)
Title: Hybrid polypeptides with selectable properties
Inventor: LEVY ODILE ESTHER
IPC: C07K14/575
Filed: 2005-02-11
Abstract: Provided is a hybrid polypeptide exhibiting at least two hormonal activities, said hybrid polypeptide comprising a first bio-active peptide hormone module covalently linked to at least one additional bio-active peptide hormone module; wherein: the bio-active peptide hormone modules are independently selected from the group consisting of: component peptide hormones, fragments of component peptide hormones that exhibit at least one hormonal activity of the component peptide hormones, analogs and derivatives of component peptide hormones that exhibit at least one hormonal activity of the component peptide hormones, and fragments of analogs and derivatives of component peptide hormones that exhibit at least one hormonal activity of the component peptide hormones; the component peptide hormones are independently selected from at least two of the group consisting of: cholecystokinin and exendin-4; and both of the bio-active peptide hormone modules exhibit at least one hormonal activity of a component peptide hormone. The polypeptide is useful to treat hormonal diseases.
Patent NZ-580011-A (NZ)
Title: Light gauge sheet metal channel and concrete composite floor slab and support structures
Inventor: DAGG HAYDEN
IPC: E04B1/24
Filed: 2008-03-27
Abstract: Disclosed is a light gauge support structure for supporting a cementitious floor slab acting together in a composite of the support structure with the cementitious slab providing mutual support. The support structure comprises light gauge sheeting for supporting the cementitious slab in the resultant composite along with a plurality of joists for underlying and supporting the light gauge sheeting. Each joist being sufficiently closely spaced to adjacent joist(s) so that the gauge sheeting is able to support the cementitious slab thereon once cured. The structure has at least one channel section that has top and bottom flanges interconnected by a web formed from light gauge steel. Each joist comprises either of top and bottom chords interconnected by web members in an open web construction, or a beam that comprises a planar elongate web interconnecting opposing torsionally rigid elongate hollow flanges. Each joist has an open web construction, the web members are aligned perpendicular to the top and bottom chords, and external faces of the webs are welded to the chords at spacings along the joist that are equal to the depth of the joist. The joists are supported by the at least one channel section, the joists projecting from the at least one channel section and having one end thereof disposed between the top and bottom flanges, whereby the top chord or one of the hollow flanges can be secured to the top flange, and the bottom chord or the other of the hollow flanges can be secured to the bottom chord, respectively. The joists are able to be secured to the channel section by self drilling, self tapping fasteners. A shear member is fixed to some joists so becomes partially embedded in the slab.
Patent NZ-580830-A (NZ)
Title: Fungicidal mixtures based on triazoles
Inventor: AMMERMANN EBERHARD
IPC: A01N55/00
Filed: 2003-03-04
Abstract: A synergistic mixture of prothioconazole and difenoconazole. A method for controlling harmful fungi, which comprises treating the harmful fungi, their habitat or the plants, seeds, soils, areas, materials or spaces to be kept free from them with a fungicidal mixture of prothioconazole and difenoconazole.
Patent NZ-582973-A (NZ)
Title: Remotely opening doors or gates by cellular phone call or text message
Inventor: FARNETI ALDO
IPC: G07C9/00
Filed: 2008-06-18
Abstract: An apparatus for remote opening of doors or gates of at least a building is disclosed. The apparatus comprises a plurality of units (B1 to Bn) located in a respective plurality of buildings and accessible from a plurality of external terminals (C1 to Cn) provided with a GSM module. The units are connected to electromechanical means suitable for opening and closing the doors or gates and each of the units comprises a database containing the list of the telephone numbers of the plurality of external terminals, a GSM interface (3) for connecting to the external terminals and means (3) for managing the interface and the database (20). The managing means is interrogatable by the external terminals and is suitable for commanding the electromechanical means for opening gates or doors if the telephone number of the interrogating external terminal is on the list of telephone numbers of the external terminals of the database. The apparatus comprises a central unit (1) comprising a memory provided with a database containing the list of the units located in the buildings and the list of passwords associated with the units located in the buildings and is suitable for activating the units, an interface (31) for remote connection to the units located in the buildings, a GSM interface (30) for connecting to the external terminals and means (40) for managing the interfaces (31) and the database (20). The managing means is interrogatable by the external terminals by means of sending a password and is suitable for checking whether the sent password is on the list of passwords of the database and, if the checking operation has been positive, is suitable for storing the telephone number of the interrogating external terminal and for sending data to the units located in the buildings. The data contains the telephone number of the interrogating external terminal and the validity period of the door or gates opening service.
Patent NZ-590396-A (NZ)
Title: An air pump producing high pressure using multi-stage coaxial cylinder arrangement, and with handle having sump for filtering for dust and humidity and for tool storage
Inventor: TASYAGAN BAHTIYAR
IPC: F04B33/00
Filed: 2008-08-13
Abstract: 590396 Manually operated air pump for multi-stage compression of ambient air comprises a multiple co-axial cylinder arrangement. The air inlet (3) is located in the pump handle (2), through which air passes to enter the pump. The pump handle further includes a dust and humidity filter (21) and a cavity (20) to be used as tool storage.